MED12 and neural tube defect: This is the first study that validates an NTD-related variant identified in humans by successfully recapitulating the NTD phenotype in mice by CRISPR/Cas9 technology, thus providing substantial evidence for the role of MED12 in the etiology of some human NTD cases.